Get started
Author

Gary C Calandra

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
2009 · John F. DiPersio, Edward A. Stadtmauer, et al. · Blood · 789
PDF
Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection
2004 · Craig W Hendrix, Ann C Collier, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 366
AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
2007 · G Calandra, J McCarty, et al. · Bone Marrow Transplantation · 281
Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
2009 · Douglas A. Stewart, Clayton Smith, et al. · Transplantation and Cellular Therapy · 89
PDF
Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization
2009 · G Tricot, M H Cottler-Fox, et al. · Bone Marrow Transplantation · 88
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
2009 · S Fruehauf, G Ehninger, et al. · Bone Marrow Transplantation · 69
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics
2006 · Stefan Fruehauf, Timon Seeger, et al. · Experimental Hematology · 61
Improved Mobilization of Peripheral Blood CD34 + Cells and Dendritic Cells by AMD3100 plus Granulocyte–Colony-Stimulating Factor in Non-Hodgkin's Lymphoma Patients
2007 · Yair Gazitt, Cesar O. Freytes, et al. · Stem Cells and Development · 50
CXCR4 in Clinical Hematology
2010 · Gary Calandra, Gary Bridger, et al. · Current topics in microbiology and immunology · 43
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 (Plerixafor)+G-CSF vs. G-CSF+Placebo for Mobilization in Multiple Myeloma (MM) Patients for Autologous Hematopoietic Stem Cell (aHSC) Transplantation.
2007 · John DiPersio, Edward A. Stadtmauer, et al. · Blood · 36
Plerixafor (Mozobil®) Alone to Mobilize Hematopoietic Stem Cells from Multiple Myeloma Patients for Autologous Transplantation
2010 · Neal Flomenberg, Raymond L. Comenzo, et al. · Transplantation and Cellular Therapy · 33
PDF
Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance.
2006 · Michael Andreeff, Sergej Konoplev, et al. · Blood · 28
A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment
2009 · Ronald MacFarland, Marjie L. Hard, et al. · Transplantation and Cellular Therapy · 26
A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled, Comparative Trial of AMD3100 (Plerixafor)+G-CSF vs. Placebo+G-CSF in Non-Hodgkin’s Lymphoma (NHL) Patients for Autologous Hematopoietic Stem Cell (aHSC) Transplantation.
2007 · John F. DiPersio, Ivana Micallef, et al. · Blood · 26
Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma
2007 · Uta Oelschlaegel, Martin Bornhauser, et al. · Annals of Hematology · 26
Successful Stem Cell Mobilization Rescue by AMD3100 (Plerixafor)+G-CSF for Patients Who Failed Primary Mobilization: Results from the Phase III (3101-NHL) Study.
2007 · Ivana Micallef, Patrick J. Stiff, et al. · Blood · 18
A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients with Advanced Hematological Malignancies.
2004 · Steven M. Devine, Jesper Bonde, et al. · Blood · 17
Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors
2012 · M E Horwitz, G Long, et al. · Bone Marrow Transplantation · 16
Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease
2009 · Arnon Blum, Richard W. Childs, et al. · Cytotherapy · 11
Novel Developments in Stem Cell Mobilization
2012 · Fruehauf, Stefan, Calandra, Gary, et al. · Springer eBooks · 9
In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070
2004 · Dominique Schols, Kurt Vermeire, et al. · Abstract book · 9
Months Report from the Phase 3 Study of Plerixafor+G-CSF VS. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with NHL.
2008 · John F. DiPersio, Ivana NM Micallef, et al. · Blood · 8
12 Months Report from a Phase 3 Study of Plerixafor+G-CSF Vs. Placebo+G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with Multiple Myeloma
2008 · John F. DiPersio, Edward A. Stadtmauer, et al. · Blood · 8
Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.
2004 · Michael J. Dugan, Luke P. Akard, et al. · Blood · 8
HLA-Matched Sibling Donor Stem Cell Mobilization Can Be Safely and Effectively Reduced from a Five Day to a One Day Process by a Direct Antagonist of the CXCR4/SDF-1 Interaction.
2006 · Steven M. Devine, Ravi Vij, et al. · Blood · 7
Works count: 47
Citation count: 2,190
H-index: 17
I10-index: 19
Year
Topic
Type